ATRS
Antares Pharma, Inc.
ATRS
ATRS
Delisted
ATRS was delisted on the 23rd of May, 2022.
103 hedge funds and large institutions have $185M invested in Antares Pharma, Inc. in 2017 Q2 according to their latest regulatory filings, with 36 funds opening new positions, 29 increasing their positions, 18 reducing their positions, and 17 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
21% more funds holding
Funds holding: 85 → 103 (+18)
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
Holders
103
Holding in Top 10
2
Calls
$640K
Puts
$176K
Top Buyers
| 1 | +$20.2M | |
| 2 | +$6.3M | |
| 3 | +$4.41M | |
| 4 |
PA
Perceptive Advisors
New York
|
+$4.35M |
| 5 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
+$2.79M |
Top Sellers
| 1 | -$9.66M | |
| 2 | -$9.14M | |
| 3 | -$5.76M | |
| 4 |
KCM
Kingdon Capital Management
New York
|
-$2.74M |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$1.97M |